Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Indivior Pharmaceuticals (INDV) Operating Margin (2022 - 2025)

Historic Operating Margin for Indivior Pharmaceuticals (INDV) over the last 4 years, with Q3 2025 value amounting to 13.69%.

  • Indivior Pharmaceuticals' Operating Margin rose 22900.0% to 13.69% in Q3 2025 from the same period last year, while for Sep 2025 it was 19.24%, marking a year-over-year increase of 156900.0%. This contributed to the annual value of 3.2% for FY2024, which is 35600.0% up from last year.
  • Indivior Pharmaceuticals' Operating Margin amounted to 13.69% in Q3 2025, which was up 22900.0% from 23.84% recorded in Q2 2025.
  • Indivior Pharmaceuticals' Operating Margin's 5-year high stood at 28.51% during Q2 2022, with a 5-year trough of 107.05% in Q4 2022.
  • Moreover, its 4-year median value for Operating Margin was 21.29% (2023), whereas its average is 1.13%.
  • Within the past 5 years, the most significant YoY rise in Indivior Pharmaceuticals' Operating Margin was 1275300bps (2023), while the steepest drop was -916700bps (2023).
  • Indivior Pharmaceuticals' Operating Margin (Quarter) stood at 107.05% in 2022, then skyrocketed by 119bps to 20.48% in 2023, then decreased by -25bps to 15.44% in 2024, then dropped by -11bps to 13.69% in 2025.
  • Its last three reported values are 13.69% in Q3 2025, 23.84% for Q2 2025, and 24.81% during Q1 2025.